ExploreWatchlistsPricing
  1. JP-listed companies
  2. SANTEN PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Pretax margin (%)

SANTEN PHARMACEUTICAL CO.,LTD. (4536)

Market cap
¥606.1B
P/E ratio
17.3x
Santen Pharmaceutical develops and sells eye care medicines and medical devices worldwide, specializing in ophthalmology products for both prescription and over-the-counter markets.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Mar 31, 202515.8+59.98%
Mar 31, 20249.9-576.04%
Mar 31, 2023-2.1-115.54%
Mar 31, 202213.4+168.87%
Mar 31, 20215-62.55%
Mar 31, 202013.3-27.89%
Mar 31, 201918.4+5.56%
Mar 31, 201817.5+9.20%
Mar 31, 201716-60.72%
Mar 31, 201640.7+83.68%
Mar 31, 201522.2+8.48%
Mar 31, 201420.4-5.02%
Mar 31, 201321.5-11.44%
Mar 31, 201224.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat